Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00876486
Recruitment Status : Completed
First Posted : April 6, 2009
Last Update Posted : May 1, 2017
Information provided by (Responsible Party):
Samyang Biopharmaceuticals Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2013
  Actual Study Completion Date : November 2013